NeuroLaunch is the world’s first accelerator program specifically for neuroscience startups. The firm focuses on early-stage investments, particularly in the pre-seed stage, providing seed funding to nascent companies in the neuroscience sector. NeuroLaunch offers a specialized 90-day curriculum designed to accelerate the growth of high-tech neuroscience startups through lean methodologies.
Notable portfolio companies include Neurish, which has raised $20,000. NeuroLaunch is led by a network of world-class mentors and forms strategic partnerships to support its portfolio companies. The firm also facilitates direct introductions to neuro-oriented venture capitalists and angel investors, enhancing the growth prospects of its startups.
NeuroLaunch - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Pre-Seed1 (100.0%)
Stage Mix
Pre-Seed 100%
Concentration shown as share of disclosed investments by stage.
